Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Comment: Radiotherapy after mastectomy for breast cancer that has spread to just a few lymph nodes

Share :

EBCC 9

19 - 21 Mar 2014
Published: 1 Apr 2014
Views: 3193
Rating:
Save
Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK

Dr Hilary Dobson gives a comment to ecancertv at EBCC 9 on research finding that radiotherapy after mastectomy was worthwhile even if the disease had only spread from 1-3 lymph nodes.

More info on the research can be found here and an interview with the authors here.

Related Videos

Breast and emerging indications for IORT

Dr David Martinez Perez - AUNA, Lima, Peru
Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023

Neo-adjuvant therapy for different cancers in the Philippines

Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines
Neo-adjuvant therapy for different cancers in the Philippines ( Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines )
4 Apr 2023

The pros and cons of breast IORT and ultra hypofractionation (FR)

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France
The pros and cons of breast IORT and ultra hypofractionation (FR) ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )
4 Apr 2023

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )
16 Mar 2023

The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival

Dr Jayant Vaidya - University College London, London, UK
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival ( Dr Jayant Vaidya - University College London, London, UK )
9 Mar 2023

Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer

Dr Jayant Vaidya - University College London, London, UK
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )
9 Mar 2023

IORT at Institute Paoli-Calmettes in France

Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France
IORT at Institute Paoli-Calmettes in France ( Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France )
6 Mar 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation